<DOC>
	<DOCNO>NCT00536042</DOCNO>
	<brief_summary>The tetracycline minocycline , addition anti-infective property , anti-inflammatory property may use treatment asthma . This study evaluate benefit minocycline add-on therapy adult asthma .</brief_summary>
	<brief_title>Open-Label Trial Use Minocycline Treatment Asthma</brief_title>
	<detailed_description>Adult asthmatic ( age 18 75 year ) history moderate severe persistent asthma give minocycline capsule add-on therapy treatment asthma . Treatment one year . Dosing begin 150 mg twice daily increase every eight week 50mg BID maximum 250 mg twice daily . This per patient tolerance minocycline cause dizziness stomach upset , well effect liver enzymes.Patients undergo routine blood toxicity screen every two month , time spirometry perform Exclusion criterion : pregnant woman ( adequate contraception mandate ) previous history hypersensitivity tetracycline , chronic liver disease Outcome measure : improvement FEV1 spirometric parameter , decrease oral steroid requirement , change total serum IgE , improvement quality life</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Adults ( age 18 75 yr ) Mild severe asthma History current oral steroid use control asthma atopy Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>minocycline</keyword>
	<keyword>asthma</keyword>
	<keyword>oral steroid</keyword>
	<keyword>IgE</keyword>
</DOC>